Richard Croker
BSc MSc
Honorary Research Fellow
Richard is an honorary research fellow in the EBM DataLab team, focusing on the OpenPrescribing project.
He qualified as a pharmacist in 1996, and has worked as a pharmaceutical adviser for the NHS for 15 years. He is currently also the Head of Medicines Optimisation for Northern, Eastern and Western Devon CCG.
Richard has a BSc in Pharmacy from the University of Portsmouth, where his final year dissertation was on the use of computer-aided learning in stereochemistry, and an MSc in Health Informatics from Swansea University, where his dissertation centred on the validity of prescribing denominators.
He also spends his time applying medicines optimisation principles to improving pathology services in the NHS.
Key publications
-
New mechanism to identify cost savings in English NHS prescribing: Minimising 'price per unit', a cross-sectional study
Journal article
Croker R. et al, (2018), BMJ Open, 8
-
The clinician impact and financial cost to the NHS of litigation over pregabalin: A cohort study in English primary care
Journal article
Croker R. et al, (2018), BMJ Open, 8
-
Pregabalin: What the patent litigation means for doctors and drug companies
Journal article
Smyth D. et al, (2018), BMJ (Online), 361
-
Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care
Journal article
Walker AJ. et al, (2018), Journal of the Royal Society of Medicine, 111, 203 - 213
Recent publications
-
Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY
Journal article
The OpenSAFELY Collaborative None. et al, (2021)
-
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform
Journal article
The OpenSAFELY Collaborative None. et al, (2021)
-
OpenSAFELY NHS Service Restoration Observatory 1: describing trends and variation in primary care clinical activity for 23.3 million patients in England during the first wave of COVID-19
Journal article
The OpenSAFELY Collaborative None. et al, (2021)
-
OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID-19 pandemic in England
Journal article
The OpenSAFELY Collaborative None. et al, (2020)
-
Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care
Journal article
MacKenna B. et al, (2020), Journal of medical Internet research, 22